Healthcare - Biotechnology - NASDAQ - US
$ 2.36
-19.7 %
$ 81.5 M
Market Cap
-2.38
P/E
INCOME STATEMENT
170 K
REVENUE
-24.2 M
OPERATING INCOME
-28.3 M
NET INCOME
EFFICIENCY
Earnings Waterfall
Genelux Corporation
| Revenue | 170 K |
| Cost Of Revenue | 1.02 M |
| Gross Profit | -848 K |
| Operating Expenses | 24.3 M |
| Operating Income | -24.2 M |
| Other Expenses | 4.13 M |
| Net Income | -28.3 M |
Income Statement
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | |
|---|---|---|---|---|---|
| REVENUE | |||||
| Revenue | 0.2 | 11.1 | 0 | 0 | 0 |
| GROSS PROFIT | |||||
| Cost Of Revenue | 1.0 | 1.0 | 0.9 | 0.7 | 0.5 |
| Gross Profit | (0.8) | 10.1 | (0.9) | (0.7) | (0.5) |
| OPERATING INCOME | |||||
| Operating Expenses | 24.3 | 14.1 | 14.6 | 12.4 | 10.4 |
| Selling, General and Administrative Expenses | 11.6 | 5.0 | 8.3 | 6.2 | 2.9 |
| Research and Development Expenses | 12.8 | 9.1 | 6.3 | 6.2 | 7.5 |
| Operating Income | (24.2) | (3.0) | (14.6) | (12.4) | (10.9) |
| PRE-TAX INCOME | |||||
| Interest Income Expense | 4.0 | 1.4 | 1.4 | 1.2 | 0.8 |
| Total Other Income | (4.1) | (1.1) | (1.8) | (1.2) | (0.8) |
| Pre-Tax Income | (28.3) | (4.1) | (16.4) | (13.6) | (11.6) |
| NET INCOME | |||||
| Tax Provision | 0 | 1.1 | 1.4 | 1.2 | 0 |
| Net Income | (28.3) | (5.2) | (17.8) | (14.9) | (11.6) |
| EPS | 1.16 | 0.21 | 0.75 | 0.63 | 0.49 |